Literature DB >> 10885665

The role of mitochondria in the pathogenesis of neurodegenerative diseases.

G Manfredi1, M F Beal.   

Abstract

A growing body of evidence indicates that mitochondrial dysfunction may play an important role in the pathogenesis of many neurodegenerative disorders. Because mitochondrial metabolism is not only the principal source of high energy intermediates, but also of free radicals, it has been suggested that inherited or acquired mitochondrial defects could be the cause of neuronal degeneration as a consequence of energy defects and oxidative damage. Mitochondrial respiratory chain dysfunction has been reported in association with primary mitochondrial DNA abnormalities, and also as a consequence of mutations in nuclear genes directly involved in mitochondrial functions, such as SURF1, frataxin, and paraplegin. Defects of oxidative phosphorylation and increased free radical production have also been observed in diseases that are not due to primary mitochondrial abnormalities. In these cases, the mitochondrial dysfunction is likely to be an epiphenomenon, which, nevertheless, could be of importance in precipitating a cascade of events leading to cell death. In either case, understanding the role of mitochondria in the pathogenesis of neurodegenerative diseases could be important for the development of therapeutic strategies in these disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885665     DOI: 10.1111/j.1750-3639.2000.tb00278.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  22 in total

1.  Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition.

Authors:  Patrizia De Sarno; Svetlana A Shestopal; Taj D King; Anna Zmijewska; Ling Song; Richard S Jope
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

2.  Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity.

Authors:  Doreen Pomplun; Anja Voigt; Tim J Schulz; René Thierbach; Andreas F Pfeiffer; Michael Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

Review 3.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

Review 4.  Mechanisms of ethanol-induced degeneration in the developing, mature, and aging cerebellum.

Authors:  Pia Jaatinen; Jyrki Rintala
Journal:  Cerebellum       Date:  2008-04-12       Impact factor: 3.847

5.  Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the sphingolipid protein, SPTLC1.

Authors:  Scott E Stimpson; Jens R Coorssen; Simon J Myers
Journal:  J Chem Biol       Date:  2014-11-14

6.  The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria.

Authors:  W Abdel-Razaq; D A Kendall; T E Bates
Journal:  Neurochem Res       Date:  2010-12-01       Impact factor: 3.996

Review 7.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 8.  Energetic depression caused by mitochondrial dysfunction.

Authors:  Frank Norbert Gellerich; Sonata Trumbeckaite; Tobias Müller; Marcus Deschauer; Ying Chen; Zemfira Gizatullina; Stephan Zierz
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 9.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18

10.  Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Authors:  Eugenia Trushina; Roy B Dyer; John D Badger; Daren Ure; Lars Eide; David D Tran; Brent T Vrieze; Valerie Legendre-Guillemin; Peter S McPherson; Bhaskar S Mandavilli; Bennett Van Houten; Scott Zeitlin; Mark McNiven; Ruedi Aebersold; Michael Hayden; Joseph E Parisi; Erling Seeberg; Ioannis Dragatsis; Kelly Doyle; Anna Bender; Celin Chacko; Cynthia T McMurray
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.